{
  "PMC": "8377577",
  "DOI": "10.1631/jzus.b2000808",
  "PMID": "34414698",
  "PMCID": "PMC8377577",
  "title": "Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses.",
  "year": 2021,
  "source_url": "https://europepmc.org/article/PMC/PMC8377577",
  "source": "MED",
  "abstract_text": "Toll-like receptor 3 (TLR3) is a member of the TLR family, mediating the transcriptional induction of type I interferons (IFNs), proinflammatory cytokines, and chemokines, thereby collectively establishing an antiviral host response. Studies have shown that unlike other TLR family members, TLR3 is the only RNA sensor that is utterly dependent on the Toll-interleukin-1 receptor (TIR)‍-domain-containing adaptor-inducing IFN-‍β (TRIF). However, the details of how the TLR3-TRIF signaling pathway works in an antiviral response and how it is regulated are unclear. In this review, we focus on recent advances in understanding the antiviral mechanism of the TRIF pathway and describe the essential characteristics of TLR3 and its antiviral effects. Advancing our understanding of TLR3 may contribute to disease diagnosis and could foster the development of novel treatments for viral diseases.",
  "full_text": "pmc J Zhejiang Univ Sci B J Zhejiang Univ Sci B Journal of Zhejiang University. Science. B 1673-1581 1862-1783 Zhejiang University Press Hangzhou 8377577 34414698 535 10.1631/jzus.B2000808 Review Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses Toll样受体3(TLR3)调控机制及其抗病毒先天免疫效应 Chen Yujuan 1 2 Lin Junhong 1 2 Zhao Yao 1 2 Ma Xianping 1 2 http://orcid.org/0000-0001-9205-2155 Yi Huashan dyxyihuashan@swu.edu.cn 1 2 3 1 grid.263906.8 College of Veterinary Medicine, Southwest University, Chongqing, 402460 China 2 Chongqing Veterinary Science Engineering Research Center, Chongqing, 402460 China 3 grid.263906.8 Immunology Research Center, Medical Research Institute, Southwest University, Chongqing, 402460 China 28 8 2021 7 2021 22 8 609 632 22 12 2020 9 4 2021 © Zhejiang University Press 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. Toll-like receptor 3 (TLR3) is a member of the TLR family, mediating the transcriptional induction of type I interferons (IFNs) proinflammatory cytokines, and chemokines, thereby collectively establishing an antiviral host response. Studies have shown that unlike other TLR family members, TLR3 is the only RNA sensor that is utterly dependent on the Toll-interleukin-1 receptor (TIR)-domain-containing adaptor-inducing IFN-β (TRIF). However, the details of how the TLR3-TRIF signaling pathway works in an antiviral response and how it is regulated are unclear. In this review we focus on recent advances in understanding the antiviral mechanism of the TRIF pathway and describe the essential characteristics of TLR3 and its antiviral effects. Advancing our understanding of TLR3 may contribute to disease diagnosis and could foster the development of novel treatments for viral diseases. Toll样受体3(TLR3)是TLR家族的成员,介导I型干扰素、促炎细胞因子和趋化因子的转录诱导,从而共同建立宿主的抗病毒反应。研究表明,不同于其他TLR家族成员,TLR3是唯一一个完全依赖于β干扰素TIR结构域衔接蛋白(TRIF)的核糖核酸传感器。然而,TLR3-TRIF信号通路如何在抗病毒反应中起作用以及如何被调控尚不完全清楚。在这篇综述中,我们重点介绍了TRIF信号通路抗病毒机制的最新研究进展,并描述了TLR3的基本特征及其抗病毒作用。进一步了解TLR3有助于相关疾病治疗,并促进某些病毒性疾病新疗法的建立。 Key words Toll-like receptor 3 (TLR3) Toll-interleukin-1 receptor (TIR)-domain-containing adaptor-inducing interferon-β (TRIF) Innate immune Antiviral response 关键词 Toll样受体3(TLR3) β干扰素TIR结构域衔接蛋白(TRIF) 先天免疫 抗病毒反应 issue-copyright-statement © Zhejiang University Press 2021 Compliance with ethics guidelines Yujuan CHEN, Junhong LIN, Yao ZHAO, Xianping MA, and Huashan YI declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors. This work was supported by the National Key R&D Program of China (No. 2018YFD0501705), the Chongqing Basic Research Program (No. cstc2018jcyjAX0615), and the Fundamental Research Funds for the Central Universities (Nos. XDJK2018C059 and XDJK2018C060), China. We thank LetPub ( http://www.letpub.com ) for its linguistic assistance and scientific consultation during the preparation of this manuscript. Author contributions Huashan YI, Yujuan CHEN, and Xianping MA were responsible for conceptualization; Yujuan CHEN, Junhong LIN, and Yao ZHAO for article writing, data collection, and manuscript revision; Yujuan CHEN for picture design; and Xianping MA and Huashan YI for supervision. All authors have read and approved the final manuscript. References Abston ED Coronado MJ Bucek A TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4 Am J Phys Regul Integr Comp Phys 2013 304 4 R267 R277 Agier J Żelechowska P Kozłowska E Expression of surface and intracellular Toll-like receptors by mature mast cells Cent Eur J Immunol 2016 41 4 333 338 10.5114/ceji.2016.65131 28450795 Alexopoulou L Holt AC Medzhitov R Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 Nature 2001 413 6857 732 738 10.1038/35099560 11607032 Alvarez-Carbonell D Garcia-Mesa Y Milne S Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells Retrovirology 2017 14 9 10.1186/s12977-017-0335-8 28166799 Ameyar M Wisniewska M Weitzman JB A role for AP-1 in apoptosis: the case for and against Biochimie 2003 85 8 747 752 10.1016/j.biochi.2003.09.006 14585541 An BY Xie Q Lin LY Expression of Toll-like receptor 3 on peripheral blood dendritic cells in HBeAg positive patients with chronic hepatitis B Chin J Hepatol 2007 15 10 729 733 Antosz H Choroszyńska D Negative regulation of Toll-like receptor signalling Postepy Hig Med Dosw 2013 67 339 350 10.5604/17322693.1046538 Assar S Arababadi MK Ahmadabadi BN Occult hepatitis B virus (HBV) infection: a global challenge for medicine Clin Lab 2012 58 11–12 1225 1230 23289193 Baratchian M Davis CA Shimizu A Distinct activation mechanisms of NF-κB regulator inhibitor of NF-κB kinase (IKK) by isoforms of the cell death regulator cellular FLICE-like inhibitory protein (cFLIP) J Biol Chem 2016 291 14 7608 7620 10.1074/jbc.M116.718122 26865630 Barton GM Kagan JC A cell biological view of Toll-like receptor function: regulation through compartmentalization Nat Rev Immunol 2009 9 8 535 542 10.1038/nri2587 19556980 Bhargavan B Woollard SM Kanmogne GD Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication Cell Signal 2016 28 2 7 22 10.1016/j.cellsig.2015.11.005 26569339 Blasius AL Beutler B Intracellular Toll-like receptors Immunity 2010 32 3 305 315 10.1016/j.immuni.2010.03.012 20346772 Boone DL Turer EE Lee EG The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses Nat Immunol 2004 5 10 1052 1060 10.1038/ni1110 15334086 Botos I Liu L Wang Y The Toll-like receptor 3: dsRNA signaling complex Biochim Biophys Acta Gene Regul Mech 2009 1789 9–10 667 674 10.1016/j.bbagrm.2009.06.005 Breckpot K Escors D Arce F HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7 J Virol 2010 84 11 5627 5636 10.1128/JVI.00014-10 20237085 Bugge M Bergstrom B Eide OK Surface Tolllike receptor 3 expression in metastatic intestinal epithelial cells induces inflammatory cytokine production and promotes invasiveness J Biol Chem 2017 292 37 15408 15425 10.1074/jbc.M117.784090 28717003 Cao LL Liu SD Li YF The nuclear matrix protein SAFA surveils viral RNA and facilitates immunity by activating antiviral enhancers and super-enhancers Cell Host Microbe 2019 26 3 369 384.e8 10.1016/j.chom.2019.08.010 31513772 Cao Y Sun Y Chang HY The E3 ubiquitin ligase RNF182 inhibits TLR-triggered cytokine production through promoting p65 ubiquitination and degradation FEBS Lett 2019 593 22 3210 3219 10.1002/1873-3468.13583 31432514 Cartwright T Perkins ND Wilson CL NFKB1: a suppressor of inflammation, ageing and cancer FEBS J 2016 283 10 1812 1822 10.1111/febs.13627 26663363 Carty M Bowie AG SARM: from immune regulator to cell executioner Biochem Pharmacol 2019 161 52 62 10.1016/j.bcp.2019.01.005 30633870 Chen CY Shih YC Hung YF Beyond defense: regulation of neuronal morphogenesis and brain functions via Toll-like receptors J Biomed Sci 2019 26 90 10.1186/s12929-019-0584-z 31684953 Chen HW Yang YK Xu H Ring finger protein 166 potentiates RNA virus-induced interferon-β production via enhancing the ubiquitination of TRAF3 and TRAF6 Sci Rep 2015 5 14770 10.1038/srep14770 26456228 Cheng L Wang Q Li GM TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs J Clin Invest 2018 128 10 4387 4396 10.1172/JCI99005 30148455 Choe J Kelker MS Wilson IA Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain Science 2005 309 5734 581 585 10.1126/science.1115253 15961631 Corcoran SE O’Neill LAJ HIF1α and metabolic reprogramming in inflammation J Clin Invest 2016 126 10 3699 3707 10.1172/JCI84431 27571407 Corsten MF Schroen B Heymans S Inflammation in viral myocarditis: friend or foe? Trends Mol Med 2012 18 7 426 437 10.1016/j.molmed.2012.05.005 22726657 Cui J Li YY Zhu L NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4 Nat Immunol 2012 13 4 387 395 10.1038/ni.2239 22388039 Daffis S Samuel MA Suthar MS Toll-like receptor 3 has a protective role against West Nile virus infection J Virol 2008 82 21 10349 10358 10.1128/JVI.00935-08 18715906 Diehl GE Yue HH Hsieh K TRAIL-R as a negative regulator of innate immune cell responses Immunity 2004 21 6 877 889 10.1016/j.immuni.2004.11.008 15589175 Dong R Chu ZG Yu FX Contriving multi-epitope subunit of vaccine for COVID-19: immunoinformatics approaches Front Immunol 2020 11 1784 10.3389/fimmu.2020.01784 32849643 Doyle M Jantsch MF New and old roles of the double-stranded RNA-binding domain J Struct Biol 2002 140 1–3 147 153 10.1016/S1047-8477(02)00544-0 12490163 Emmerich CH Ordureau A Strickson S Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains Proc Natl Acad Sci USA 2013 110 38 15247 15252 10.1073/pnas.1314715110 23986494 Ermolaeva MA Michallet MC Papadopoulou N Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses Nat Immunol 2008 9 9 1037 1046 10.1038/ni.1638 18641654 Esfandiarei M McManus BM Molecular biology and pathogenesis of viral myocarditis Annu Rev Pathol Mech Dis 2008 3 127 155 10.1146/annurev.pathmechdis.3.121806.151534 Esposito S Molteni CG Giliani S Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children Virol J 2012 9 270 10.1186/1743-422X-9-270 23151015 Ewald SE Engel A Lee J Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase J Exp Med 2011 208 4 643 651 10.1084/jem.20100682 21402738 Fang F Ooka K Sun XY A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling J Immunol 2013 191 6 2956 2966 10.4049/jimmunol.1300376 23956427 Fischer J Koukoulioti E Schott E Polymorphisms in the Toll-like receptor 3 ( TLR3 ) gene are associated with the natural course of hepatitis B virus infection in caucasian population Sci Rep 2018 8 12737 10.1038/s41598-018-31065-6 30143709 Fitzgerald KA Kagan JC Toll-like receptors and the control of immunity Cell 2020 180 6 1044 1066 10.1016/j.cell.2020.02.041 32164908 Freedman NJ Shenoy SK Regulation of inflammation by β-arrestins: not just receptor tales Cell Signal 2018 41 41 45 10.1016/j.cellsig.2017.02.008 28189586 Frobøse H Rønn SG Heding PE Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex Mol Endocrinol 2006 20 7 1587 1596 10.1210/me.2005-0301 16543409 Funami K Matsumoto M Oshiumi H The cytoplasmic ‘linker region’ in Toll-like receptor 3 controls receptor localization and signaling Int Immunol 2004 16 8 1143 1154 10.1093/intimm/dxh115 15226270 Funami K Sasai M Ohba Y Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA J Immunol 2007 179 10 6867 6872 10.4049/jimmunol.179.10.6867 17982077 Funami K Sasai M Oshiumi H Homooligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-κB and interferon regulatory factor-3 activation J Biol Chem 2008 283 26 18283 18291 10.1074/jbc.M801013200 18450748 Funami K Matsumoto M Obuse C 14-3-3-ζ participates in TLR3-mediated TICAM-1 signal-platform formation Mol Immunol 2016 73 60 68 10.1016/j.molimm.2016.03.010 27058640 Galluzzi L Green DR Autophagy-independent functions of the autophagy machinery Cell 2019 177 7 1682 1699 10.1016/j.cell.2019.05.026 31199916 Gao D Wang XD Jin GY Research progress of Toll-like receptor and ligand complex structure China J Cell Mol Immunol 2015 31 4 553 556 Gao JJ Tian ZX Yang X Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Biosci Trends 2020 14 1 72 73 10.5582/bst.2020.01047 32074550 Geng PL Song LX An HJ Toll-like receptor 3 is associated with the risk of HCV infection and HBV-related diseases Medicine (Baltimore) 2016 95 21 e2302 10.1097/MD.0000000000002302 27227908 Gong T Liu L Jiang W DAMP-sensing receptors in sterile inflammation and inflammatory diseases Nat Rev Immunol 2020 20 2 95 112 10.1038/s41577-019-0215-7 31558839 Gosu V Son S Shin D Insights into the dynamic nature of the dsRNA-bound TLR3 complex Sci Rep 2019 9 3652 10.1038/s41598-019-39984-8 30842554 Gowen BB Hoopes JD Wong MH TLR3 deletion limits mortality and disease severity due to phlebo-virus infection J Immunol 2006 177 9 6301 6307 10.4049/jimmunol.177.9.6301 17056560 Guan WJ Ni ZY Hu Y Clinical characteristics of coronavirus disease 2019 in China N Engl J Med 2020 382 18 1708 1720 10.1056/NEJMoa2002032 32109013 Guo BC Cheng GH Modulation of the interferon antiviral response by the TBK1/IKKI adaptor protein TANK J Biol Chem 2007 282 16 11817 11826 10.1074/jbc.M700017200 17327220 Han CF Jin J Xu S Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b Nat Immunol 2010 11 8 734 742 10.1038/ni.1908 20639876 Hardarson HS Baker JS Yang Z Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury Am J Physiol Heart Circ Physiol 2007 292 1 H251 H258 10.1152/ajpheart.00398.2006 16936008 Hase K Contu VR Kabuta C Cytosolic domain of SIDT2 carries an arginine-rich motif that binds to RNA/DNA and is important for the direct transport of nucleic acids into lysosomes Autophagy 2020 16 11 1974 1988 10.1080/15548627.2020.1712109 31944164 He X Li Y Li C USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6 J Mol Cell Biol 2013 5 1 39 47 10.1093/jmcb/mjs024 22611252 Hidaka F Matsuo S Muta T A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy Clin Immunol 2006 119 2 188 194 10.1016/j.clim.2006.01.005 16517210 Honda K Takaoka A Taniguchi T Type I inteferon gene induction by the interferon regulatory factor family of transcription factors Immunity 2006 25 3 349 360 10.1016/j.immuni.2006.08.009 16979567 Hu YH Zhang Y Jiang LQ WDFY1 mediates TLR3/4 signaling by recruiting TRIF EMBO Rep 2015 16 4 447 455 10.15252/embr.201439637 25736436 Huh HD Lee E Shin J STRAP positively regulates TLR3-triggered signaling pathway Cell Immunol 2017 318 55 60 10.1016/j.cellimm.2017.06.005 28651742 Huo CY Jin Y Zou SM Lethal influenza A virus preferentially activates TLR3 and triggers a severe inflammatory response Virus Res 2018 257 102 112 10.1016/j.virusres.2018.09.012 30248373 Ismail S Ahmad S Azam SS Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine J Mol Liq 2020 314 113612 10.1016/j.molliq.2020.113612 32834259 Itoh K Watanabe A Funami K The clathrin-mediated endocytic pathway participates in dsRNA-induced IFN-β production J Immunol 2008 181 8 5522 5529 10.4049/jimmunol.181.8.5522 18832709 Jiang Y Ye L Cui Y Effects of Lactobacillus rhamnosus GG on the maturation and differentiation of dendritic cells in rotavirus-infected mice Benef Microbes 2017 8 4 645 656 10.3920/BM2016.0157 28670908 Johnsen IB Nguyen TT Ringdal M Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling EMBO J 2006 25 14 3335 3346 10.1038/sj.emboj.7601222 16858407 Kang JY Lee JO Structural biology of the Toll-like receptor family Annu Rev Biochem 2011 80 917 941 10.1146/annurev-biochem-052909-141507 21548780 Karikó K Bhuyan P Capodici J Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Tolllike receptor 3 J Immunol 2004 172 11 6545 6549 10.4049/jimmunol.172.11.6545 15153468 Karikó K Buckstein M Ni H Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA Immunity 2005 23 2 165 175 10.1016/j.immuni.2005.06.008 16111635 Karimi-Googheri M Arababadi MK TLR3 plays significant roles against hepatitis B virus Mol Biol Rep 2014 41 5 3279 3286 10.1007/s11033-014-3190-x 24477590 Kawai T Akira S Signaling to NF-κB by Toll-like receptors Trends Mol Med 2007 13 11 460 469 10.1016/j.molmed.2007.09.002 18029230 Kawai T Akira S The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors Nat Immunol 2010 11 5 373 384 10.1038/ni.1863 20404851 Kawasaki T Kawai T Toll-like receptor signaling pathways Front Immunol 2014 5 461 10.3389/fimmu.2014.00461 25309543 Kayagaki N Phung Q Chan S A deubiquitinase that regulates type I interferon production Science 2007 318 5856 1628 1632 10.1126/science.1145918 17991829 Kindberg E Vene S Mickiene A A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection J Infect Dis 2011 203 4 523 528 10.1093/infdis/jiq082 21216866 Kleinman ME Yamada K Takeda A Sequence-and target-independent angiogenesis suppression by siRNA via TLR3 Nature 2008 452 7187 591 597 10.1038/nature06765 18368052 Kohl B Granitzka V Singh A Comparison of backbone dynamics of the p50 dimerization domain of NFκB in the homodimeric transcription factor NFκB1 and in its heterodimeric complex with RelA (p65) Protein Sci 2019 28 12 2064 2072 10.1002/pro.3736 31587407 Kong KF Delroux K Wang XM Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly J Virol 2008 82 15 7613 7623 10.1128/JVI.00618-08 18508883 Kramer LD Styer LM Ebel GD A global perspective on the epidemiology of West Nile virus Annu Rev Entomol 2008 53 61 81 10.1146/annurev.ento.53.103106.093258 17645411 Kulka M Alexopoulou L Flavell RA Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3 J Allergy Clin Immunol 2004 114 1 174 182 10.1016/j.jaci.2004.03.049 15241362 Kumeta H Sakakibara H Enokizono Y The N-terminal domain of TIR domain-containing adaptor molecule-1, TICAM-1 J Biomol NMR 2014 58 3 227 230 10.1007/s10858-014-9819-1 24500696 Lafaille FG Pessach IM Zhang SY Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells Nature 2012 491 7426 769 773 10.1038/nature11583 23103873 Langston PK Nambu A Jung J Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses Nat Immunol 2019 20 9 1186 1195 10.1038/s41590-019-0453-7 31384058 Laporte SA, Scott MGH, 2019. β-Arrestins: multitask scaffolds orchestrating the where and when in cell signalling. In : Scott MGH, Laporte SA (Eds.), Beta-Arrestins. Humana Press, New York, p.9–55. 10.1007/978-1-4939-9158-7_2 Lee HK Dunzendorfer S Soldau K Double-stranded RNA-mediated TLR3 activation is enhanced by CD14 Immunity 2006 24 2 153 163 10.1016/j.immuni.2005.12.012 16473828 Lee KG Xu SL Kang ZH Bruton’s tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response Proc Natl Acad Sci USA 2012 109 15 5791 5796 10.1073/pnas.1119238109 22454496 Lei CQ Wu X Zhong X USP19 inhibits TNF-α-and IL-1β-triggered NF-κB activation by deubiquitinating TAK1 J Immunol 2019 203 1 259 268 10.4049/jimmunol.1900083 31127032 Leonard JN Ghirlando R Askins J The TLR3 signaling complex forms by cooperative receptor dimerization Proc Natl Acad Sci USA 2008 105 1 258 263 10.1073/pnas.0710779105 18172197 Leung YHC Nicholls JM Ho CK Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice J Gen Virol 2014 95 1870 1879 10.1099/vir.0.066258-0 24878639 Li FB Li Y Liang HC HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection J Clin Invest 2018 128 9 4148 4162 10.1172/JCI120406 29920190 Li K Li NL Wei D Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates Hepatology 2012 55 3 666 675 10.1002/hep.24763 22030901 Li ST Wang LY Berman M Mapping a dynamic innate immunity protein interaction network regulating type I interferon production Immunity 2011 35 3 426 440 10.1016/j.immuni.2011.06.014 21903422 Li WW Nie Y Yang Y Ubiquitination of TLR3 by TRIM3 signals its ESCRT-mediated trafficking to the endolysosomes for innate antiviral response Proc Natl Acad Sci USA 2020 117 38 23707 23716 10.1073/pnas.2002472117 32878999 Limmon GV Arredouani M McCann KL Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA FASEB J 2008 22 1 159 167 10.1096/fj.07-8348com 17709607 Liu GK The Effect of Ubiquitin Ligase Nedd4l on Toll-like Receptor Signaling Transduction of Macrophage 2019 Shanghai, China the Second Military Medical University Liu GQ Gack MU Distinct and orchestrated functions of RNA sensors in innate immunity Immunity 2020 53 1 26 42 10.1016/j.immuni.2020.03.017 32668226 Liu GQ Lu Y Thulasi Raman SN Nuclear-resident RIG-I senses viral replication inducing antiviral immunity Nat Commun 2018 9 3199 10.1038/s41467-018-05745-w 30097581 Liu L Botos I Wang Y Structural basis of Toll-like receptor 3 signaling with double-stranded RNA Science 2008 320 5874 379 381 10.1126/science.1155406 18420935 Liu SQ Cai X Wu JX Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation Science 2015 347 6227 aaa2630 10.1126/science.aaa2630 25636800 Loo YM Gale M Immune signaling by RIG-I-like receptors Immunity 2011 34 5 680 692 10.1016/j.immuni.2011.05.003 21616437 Lu D Song J Sun YZ Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders J Autoimmun 2018 94 156 165 10.1016/j.jaut.2018.07.019 30100102 Luo JQ Obmolova G Malia TJ Lateral clustering of TLR3: dsRNA signaling units revealed by TLR3ecd: 3fabs quaternary structure J Mol Biol 2012 421 1 112 124 10.1016/j.jmb.2012.05.006 22579623 Luo L Curson JEB Liu LP SCIMP is a universal Toll-like receptor adaptor in macrophages J Leukoc Biol 2020 107 2 251 262 10.1002/JLB.2MA0819-138RR 31468585 Mahita J Sowdhamini R Integrative modelling of TIR domain-containing adaptor molecule inducing interferon-β (TRIF) provides insights into its autoinhibited state Biol Direct 2017 12 9 10.1186/s13062-017-0179-0 28427457 Mahita J Sowdhamini R Investigating the effect of key mutations on the conformational dynamics of Tolllike receptor dimers through molecular dynamics simulations and protein structure networks Proteins 2018 86 4 475 490 10.1002/prot.25467 29383743 Maire M Parent R Morand AL Characterization of the double-stranded RNA responses in human liver progenitor cells Biochem Biophys Res Commun 2008 368 3 556 562 10.1016/j.bbrc.2008.01.123 18258184 Marshall JS Portales-Cervantes L Leong E Mast cell responses to viruses and pathogen products Int Mol Sci 2019 20 17 4241 10.3390/ijms20174241 Martin-Gayo E Yu XG Dendritic cell immune responses in HIV-1 controllers Curr HIV/AIDS Rep 2017 14 1 1 7 10.1007/s11904-017-0345-0 28110421 Matsumoto M Funami K Tanabe M Subcellular localization of Toll-like receptor 3 in human dendritic cells J Immunol 2003 171 6 3154 3162 10.4049/jimmunol.171.6.3154 12960343 Matsumoto M Oshiumi H Seya T Antiviral responses induced by the TLR3 pathway Rev Med Virol 2011 21 2 67 77 10.1002/rmv.680 21312311 Matsumoto M Takeda Y Seya T Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy Expert Opin Biol Ther 2020 20 8 937 946 10.1080/14712598.2020.1749260 32223572 Meng D Huo CY Wang M Influenza a viruses replicate productively in mouse mastocytoma cells (P815) and trigger pro-inflammatory cytokine and chemokine production through TLR3 signaling pathway Front Microbiol 2016 7 2130 28127293 Meylan E Burns K Hofmann K RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation Nat Immunol 2004 5 5 503 507 10.1038/ni1061 15064760 Mickienė A Pakalnienė J Nordgren J Polymorphisms in chemokine receptor 5 and Toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the Lithuanian population PLoS ONE 2014 9 9 e106798 10.1371/journal.pone.0106798 25226020 Mielcarska MB Bossowska-Nowicka M Toka FN Functional failure of TLR3 and its signaling components contribute to herpes simplex encephalitis J Neuroimmunol 2018 316 65 73 10.1016/j.jneuroim.2017.12.011 29305044 Mineev KS Goncharuk SA Arseniev AS Toll-like receptor 3 transmembrane domain is able to perform various homotypic interactions: an NMR structural study FEBS Lett 2014 588 21 3802 3807 10.1016/j.febslet.2014.08.031 25217833 Mitchell S Vargas J Hoffmann A Signaling via the NFκB system WIREs Syst Biol Med 2016 8 3 227 241 10.1002/wsbm.1331 Mortaz E Adcock IM Abedini A The role of pattern recognition receptors in lung sarcoidosis Eur Pharmacol 2017 808 44 48 10.1016/j.ejphar.2017.01.020 Mosaad YM Metwally SS Farag RE Association between Toll-like receptor 3 ( TLR3 ) rs3775290, TLR7 rs179008, TLR9 rs352140 and chronic HCV Immunol Invest 2019 48 3 321 332 10.1080/08820139.2018.1527851 30321082 Negishi H Osawa T Ogami K A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity Proc Natl Acad Sci USA 2008 105 51 20446 20451 10.1073/pnas.0810372105 19074283 Nguyen H Gazy N Venketaraman V A role of intracellular Toll-like receptors (3, 7, and 9) in response to Mycobacterium tuberculosis and co-infection with HIV Int J Mol Sci 2020 21 17 6148 10.3390/ijms21176148 Nguyen VP Chen J Petrus MN A new domain in the Toll/IL-1R domain-containing adaptor inducing interferon-β factor protein amino terminus is important for tumor necrosis factor-α receptor-associated factor 3 association, protein stabilization and interferon signaling J Innate Immun 2014 6 3 377 393 10.1159/000356408 24577058 Ondondo BO Brunham RC Harrison WG Frequency and magnitude of Chlamydia trachomatis elementary body- and heat shock protein 60-stimulated interferon γ responses in peripheral blood mononuclear cells and endometrial biopsy samples from women with high exposure to infection J Infect Dis 2009 199 12 1771 1779 10.1086/599095 19419333 Oshiumi H Matsumoto M Funami K TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction Nat Immunol 2003 4 2 161 167 10.1038/ni886 12539043 Oshiumi H Okamoto M Fujii K The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection J Immunol 2011 187 10 5320 5327 10.4049/jimmunol.1101503 21998457 Pabo CO Sauer RT Protein-DNA recognition Annu Rev Biochem 1984 53 293 321 10.1146/annurev.bi.53.070184.001453 6236744 Park GB Hur DY Kim YS TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea J Cell Mol Med 2015 19 5 1042 1054 10.1111/jcmm.12495 25754842 Patel S Sinigaglia A Barzon L Role of NS1 and TLR3 in pathogenesis and immunity of WNV Viruses 2019 11 7 603 10.3390/v11070603 Patra MC Batool M Haseeb M A computational probe into the structure and dynamics of the full-length Toll-like receptor 3 in a phospholipid bilayer Int J Mol Sci 2020 21 8 2857 10.3390/ijms21082857 Peisley A Hur S Multi-level regulation of cellular recognition of viral dsRNA Cell Mol Life Sci 2013 70 11 1949 1963 10.1007/s00018-012-1149-4 22960755 Pelka K Bertheloot D Reimer E The chaperone UNC93B1 regulates Toll-like receptor stability independently of endosomal TLR transport Immunity 2018 48 5 911 922.e7 10.1016/j.immuni.2018.04.011 29768176 Peng J Yuan Q Lin B SARM inhibits both TRIF- and MyD88-mediated AP-1 activation Eur J Immunol 2010 40 6 1738 1747 10.1002/eji.200940034 20306472 Perales-Linares R Navas-Martin S Toll-like receptor 3 in viral pathogenesis: friend or foe? Immunology 2013 140 2 153 167 10.1111/imm.12143 23909285 Piliponsky AM Romani L The contribution of mast cells to bacterial and fungal infection immunity Immunol Rev 2018 282 1 188 197 10.1111/imr.12623 29431211 Pott J Stockinger S Torow N Age-dependent TLR3 expression of the intestinal epithelium contributes to rotavirus susceptibility PLoS Pathog 2012 8 5 e1002670 10.1371/journal.ppat.1002670 22570612 Prasad K Khatoon F Rashid S Targeting hub genes and pathways of innate immune response in COVID-19: a network biology perspective Int J Biol Macromol 2020 163 1 8 10.1016/j.ijbiomac.2020.06.228 32599245 Rai RC Host inflammatory responses to intracellular invaders: review study Life Sci 2020 240 117084 10.1016/j.lfs.2019.117084 31759040 Rehwinkel J Gack MU RIG-I-like receptors: their regulation and roles in RNA sensing Nat Rev Immunol 2020 20 9 537 551 10.1038/s41577-020-0288-3 32203325 Ryo A Suizu F Yoshida Y Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/Rela Mol Cell 2003 12 6 1413 1426 10.1016/S1097-2765(03)00490-8 14690596 Ryzhakov G Randow F SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK EMBO J 2007 26 13 3180 3190 10.1038/sj.emboj.7601743 17568778 Saitoh T Yamamoto M Miyagishi M A20 is a negative regulator of IFN regulatory factor 3 signaling J Immunol 2005 174 3 1507 1512 10.4049/jimmunol.174.3.1507 15661910 Salio M Cerundolo V Viral immunity: cross-priming with the help of TLR3 Curr Biol 2005 15 9 R336 R339 10.1016/j.cub.2005.04.025 15886091 Sancho-Shimizu V de Diego RP Jouanguy E Inborn errors of anti-viral interferon immunity in humans Curr Opin Virol 2011 1 6 487 496 10.1016/j.coviro.2011.10.016 22347990 Sander WJ O’Neill HG Pohl CH Prostaglandin E 2 as a modulator of viral infections Front Physiol 2017 8 89 10.3389/fphys.2017.00089 28261111 Sarkar SN Smith HL Rowe TM Double-stranded RNA signaling by Toll-like receptor 3 requires specific tyrosine residues in its cytoplasmic domain J Biol Chem 2003 278 7 4393 4396 10.1074/jbc.C200655200 12509442 Sarkar SN Peters KL Elco CP Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling Nat Struct Mol Biol 2004 11 11 1060 1067 10.1038/nsmb847 15502848 Sasai M Tatematsu M Oshiumi H Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway Mol Immunol 2010 47 6 1283 1291 10.1016/j.molimm.2009.12.002 20047764 Sato R Kato A Chimura T Combating herpes-virus encephalitis by potentiating a TLR3-mTORC2 axis Nat Immunol 2018 19 10 1071 1082 10.1038/s41590-018-0203-2 30201994 Saxena M Sabado RL La Mar M Poly-ICLC, a TLR3 agonist, induces transient innate immune responses in patients with treated HIV-infection: a randomized double-blinded placebo controlled trial Front Immunol 2019 10 725 10.3389/fimmu.2019.00725 31024557 Schmid S Sachs D Tenoever BR Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus J Biol Chem 2014 289 1 299 311 10.1074/jbc.M113.519934 24275658 Schröder M Bowie AG TLR3 in antiviral immunity: key player or bystander? Trends Immunol 2005 26 9 462 468 10.1016/j.it.2005.07.002 16027039 Sesti-Costa R Françozo MCS Silva GK TLR3 is required for survival following Coxsackievirus B3 infection by driving T lymphocyte activation and polarization: the role of dendritic cells PLoS ONE 2017 12 10 e0185819 10.1371/journal.pone.0185819 28973047 Shin C Ito Y Ichikawa S MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses Sci Rep 2017 7 46097 10.1038/srep46097 28378844 Singh D Qi RS Jordan JL The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway J Biol Chem 2013 288 12 8258 8268 10.1074/jbc.M112.440883 23386607 Singh S Pandey K Rathore YS A communication network within the cytoplasmic domain of Toll-like receptors has remained conserved during evolution J Biomol Struct Dyn 2014 32 5 694 700 10.1080/07391102.2013.787545 23600666 Sioud M Innate sensing of self and non-self RNAs by Toll-like receptors Trends Mol Med 2006 12 4 167 176 10.1016/j.molmed.2006.02.004 16530484 Song GH Liu BY Li ZH E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1 Nat Immunol 2016 17 12 1342 1351 10.1038/ni.3588 27776110 Song XQ Liu S Wang WD E3 ubiquitin ligase RNF170 inhibits innate immune responses by targeting and degrading TLR3 in murine cells Cell Mol Immunol 2020 17 8 865 874 10.1038/s41423-019-0236-y 31076723 Søreng K Neufeld TP Simonsen A Membrane trafficking in autophagy Int Rev Cell Mol Biol 2018 336 1 92 10.1016/bs.ircmb.2017.07.001 29413888 Sorokin AV Kim ER Ovchinnikov LP Proteasome system of protein degradation and processing Biochemistry (Mosc) 2009 74 13 1411 1442 10.1134/S000629790913001X 20210701 Soto JA Gálvez NMS Andrade CA The role of dendritic cells during infections caused by highly prevalent viruses Front Immunol 2020 11 1513 10.3389/fimmu.2020.01513 32765522 Spearman CW Dusheiko GM Hellard M Hepatitis C Lancet 2019 394 10207 1451 1466 10.1016/S0140-6736(19)32320-7 31631857 Sun LJ Wu JX Du FH Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway Science 2013 339 6121 786 791 10.1126/science.1232458 23258413 Tabeta K Hoebe K Janssen EM The unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9 Nat Immunol 2006 7 2 156 164 10.1038/ni1297 16415873 Takahashi T Kulkarni NN Lee EY Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors Sci Rep 2018 8 4032 10.1038/s41598-018-22409-3 29507358 Takeda K Akira S Toll-like receptors Curr Protoc Immunol 2015 109 14.12.1 14.12.10 10.1002/0471142735.im1412s109 Tan YH Kagan JC Innate immune signaling organelles display natural and programmable signaling flexibility Cell 2019 177 2 384 398.e11 10.1016/j.cell.2019.01.039 30853218 Tatematsu M Ishii A Oshiumi H A molecular mechanism for Toll-IL-1 receptor domain-containing adaptor molecule-1-mediated IRF-3 activation J Biol Chem 2010 285 26 20128 20136 10.1074/jbc.M109.099101 20418377 Tavora B Mederer T Wessel KJ Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis Nature 2020 586 7828 299 304 10.1038/s41586-020-2774-y 32999457 Tjwa ETTL van Oord GW Biesta PJ Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infection J Virol 2012 86 8 4102 4109 10.1128/JVI.07000-11 22318141 Topping KD Kelly DG Investigation of binding characteristics of immobilized Toll-like receptor 3 with poly(I:C) for potential biosensor application Anal Biochem 2019 564–565 133 140 10.1016/j.ab.2018.05.023 29842862 Town T Jeng D Alexopoulou L Microglia recognize double-stranded RNA via TLR3 J Immunol 2006 176 6 3804 3812 10.4049/jimmunol.176.6.3804 16517751 Tseng PH Matsuzawa A Zhang WZ Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines Nat Immunol 2010 11 1 70 75 10.1038/ni.1819 19898473 Uehata T Takeuchi O RNA recognition and immunity—innate immune sensing and its posttranscriptional regulation mechanisms Cells 2020 9 7 1701 10.3390/cells9071701 Unterholzner L Keating SE Baran M IFI16 is an innate immune sensor for intracellular DNA Nat Immunol 2010 11 11 997 1004 10.1038/ni.1932 20890285 Wang K Liu HL He YL Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure Hum Immunol 2010 71 10 950 956 10.1016/j.humimm.2010.07.013 20667457 Wang L Wen MY Cao XT Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses Science 2019 365 6454 eaav0758 10.1126/science.aav0758 31320558 Wang P Zhao W Zhao K TRIM26 negatively regulates interferon-β production and antiviral response through polyubiquitination and degradation of nuclear IRF3 PLoS Pathog 2015 11 3 e1004726 10.1371/journal.ppat.1004726 25763818 Wang T Town T Alexopoulou L Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis Nat Med 2004 10 12 1366 1373 10.1038/nm1140 15558055 Wang Y Liu L Davies DR Dimerization of Toll-like receptor 3 (TLR3) is required for ligand binding J Biol Chem 2010 285 47 36836 36841 10.1074/jbc.M110.167973 20861016 Wang Y Yuan SC Jia X Mitochondria-localised ZNFX1 functions as a dsRNA sensor to initiate antiviral responses through MAVs Nat Cell Biol 2019 21 11 1346 1356 10.1038/s41556-019-0416-0 31685995 Wang YY Tang YW Teng L Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling Nat Immunol 2006 7 2 139 147 10.1038/ni1294 16378096 Watanabe A Tatematsu M Saeki K Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation J Biol Chem 2011 286 12 10702 10711 10.1074/jbc.M110.185793 21266579 Weber C Müller C Podszuweit A Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects) Immunology 2012 136 1 64 77 10.1111/j.1365-2567.2012.03559.x 22260507 Wilson JR de Sessions PF Leon MA West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction J Virol 2008 82 17 8262 8271 10.1128/JVI.00226-08 18562533 Witczak P Brzezińska-Błaszczyk E Agier J The response of tissue mast cells to TLR3 ligand poly(I:C) treatment J Immunol Res 2020 2020 2140694 10.1155/2020/2140694 32185237 Witherow DS Garrison TR Miller WE β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα Proc Natl Acad Sci USA 2004 101 23 8603 8607 10.1073/pnas.0402851101 15173580 Wu F Zhao S Yu B A new coronavirus associated with human respiratory disease in China Nature 2020 579 7798 265 269 10.1038/s41586-020-2008-3 32015508 Wu FY Niu ZM Zhou B PSMB1 negatively regulates the innate antiviral immunity by facilitating degradation of IKK-ε Viruses 2019 11 2 99 10.3390/v11020099 Wu HF Liu HS Zhao XY IKIP negatively regulates NF-κB activation and inflammation through inhibition of IKKα/β phosphorylation J Immunol 2020 204 2 418 427 10.4049/jimmunol.1900626 31826938 Wu JX Chen ZJ Innate immune sensing and signaling of cytosolic nucleic acids Annu Rev Immunol 2014 32 461 488 10.1146/annurev-immunol-032713-120156 24655297 Wu X Lei CQ Xia T Regulation of TRIF-mediated innate immune response by K27-linked polyubiquitination and deubiquitination Nat Commun 2019 10 4115 10.1038/s41467-019-12145-1 31511519 Xing JJ Weng LY Yuan B Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract Nat Immunol 2016 17 12 1373 1380 10.1038/ni.3580 27695001 Xue QH Zhou Z Lei XB TRIM38 negatively regulates TLR3-mediated IFN-β signaling by targeting TRIF for degradation PLoS ONE 2012 7 10 e46825 10.1371/journal.pone.0046825 23056470 Yamashita M Chattopadhyay S Fensterl V Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling Sci Signal 2012 5 233 ra50 10.1126/scisignal.2002581 22810896 Yang Q Shu HB Deciphering the pathways to antiviral innate immunity and inflammation Adv Immunol 2020 145 1 36 10.1016/bs.ai.2019.11.001 32081195 Yang Y Liao B Wang SY E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation Proc Natl Acad Sci USA 2013 110 13 5115 5120 10.1073/pnas.1220271110 23479606 Yang Y Wang SY Huang ZF The RNA-binding protein Mex3B is a coreceptor of Toll-like receptor 3 in innate antiviral response Cell Res 2016 26 3 288 303 10.1038/cr.2016.16 26823206 Ye W Hu MM Lei CQ TRIM8 negatively regulates TLR3/4-mediated innate immune response by blocking TRIF-TBK1 interaction J Immunol 2017 199 5 1856 1864 10.4049/jimmunol.1601647 28747347 Yu YX Hayward GS The ubiquitin E3 ligase RAUL negatively regulates type I interferon through ubiquitination of the transcription factors IRF7 and IRF3 Immunity 2010 33 6 863 877 10.1016/j.immuni.2010.11.027 21167755 Yuan X Gajan A Chu Q Developing TRAIL/TRAIL death receptor-based cancer therapies Cancer Metastasis Rev 2018 37 4 733 748 10.1007/s10555-018-9728-y 29541897 Yuk JM Shin DM Lee HM The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors Nat Immunol 2011 12 8 742 751 10.1038/ni.2064 21725320 Zang R Lian H Zhong X ZCCHC3 modulates TLR3-mediated signaling by promoting recruitment of TRIF to TLR3 J Mol Cell Biol 2020 12 4 251 262 10.1093/jmcb/mjaa004 32133501 Zeng WW Xu M Liu SQ Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3 Mol Cell 2009 36 2 315 325 10.1016/j.molcel.2009.09.037 19854139 Zhang JY Shen BF SHP limits TLR signaling, an inducible transcriptional corepressor Cell Mol Immunol 2011 8 6 445 446 10.1038/cmi.2011.31 21860408 Zhang L Zhao XY Zhang M Ubiquitin-specific protease 2b negatively regulates IFN-β production and antiviral activity by targeting TANK-binding kinase 1 J Immunol 2014 193 5 2230 2237 10.4049/jimmunol.1302634 25070846 Zhang LY Xiang WP Wang GL Interferon β (IFN-β) production during the double-stranded RNA (dsRNA) response in hepatocytes involves coordinated and feedforward signaling through Toll-like receptor 3 (TLR3), RNA-dependent protein kinase (PKR), inducible nitric oxide synthase (iNOS), and Src protein J Biol Chem 2016 291 29 15093 15107 10.1074/jbc.M116.717942 27226571 Zhang M Wang LJ Zhao XY TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1 J Exp Med 2012 209 10 1703 1711 10.1084/jem.20120024 22945920 Zhang Q Bastard P Liu ZY Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Science 2020 370 6515 eabd4570 10.1126/science.abd4570 32972995 Zhang SY Jouanguy E Ugolini S TLR3 deficiency in patients with herpes simplex encephalitis Science 2007 317 5844 1522 1527 10.1126/science.1139522 17872438 Zhang ZQ Kim T Bao MS DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells Immunity 2011 34 6 866 878 10.1016/j.immuni.2011.03.027 21703541 Zhao BY Shu C Gao XS Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins Proc Natl Acad Sci USA 2016 113 24 E3403 E3412 10.1073/pnas.1603269113 27302953 Zhao XB Zhu HH Yu J c-Cbl-mediated ubiquitination of IRF3 negatively regulates IFN-β production and cellular antiviral response Cell Signal 2016 28 11 1683 1693 10.1016/j.cellsig.2016.08.002 27503123 Zheng H Li Q Chen R The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-κB activation by dephosphorylating the protein kinase TAK1 J Biol Chem 2013 288 2 819 825 10.1074/jbc.M112.412643 23229544 Zheng QL Hou J Zhou Y Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27 Cell Res 2015 25 10 1121 1136 10.1038/cr.2015.108 26358190 Zheng Y Gao CJ Fine-tuning of antiviral innate immunity by ubiquitination Adv Immunol 2020 145 95 128 10.1016/bs.ai.2019.11.004 32081201 Zhong X Feng L Xu WH The zinc-finger protein ZFYVE1 modulates TLR3-mediated signaling by facilitating TLR3 ligand binding Cell Mol Immunol 2020 17 7 741 752 10.1038/s41423-019-0265-6 31388100 Zhou RY Zhang Q Xu PL TBK1, a central kinase in innate immune sensing of nucleic acids and beyond Acta Biochim Biophys Sin 2020 52 7 757 767 10.1093/abbs/gmaa051 32458982 Zhou Y Wang X Sun L Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes FASEB J 2016 30 12 4132 4140 10.1096/fj.201600696R 27605546 Zhu S Wang G Lei XQ Mex3B: a coreceptor to present dsRNA to TLR3 Cell Res 2016 26 4 391 392 10.1038/cr.2016.29 26940660",
  "plain_text": "Toll-like receptor 3 (TLR3) is a member of the TLR family, mediating the transcriptional induction of type I interferons (IFNs) proinflammatory cytokines, and chemokines, thereby collectively establishing an antiviral host response. Studies have shown that unlike other TLR family members, TLR3 is the only RNA sensor that is utterly dependent on the Toll-interleukin-1 receptor (TIR)-domain-containing adaptor-inducing IFN-β (TRIF). However, the details of how the TLR3-TRIF signaling pathway works in an antiviral response and how it is regulated are unclear. In this review we focus on recent advances in understanding the antiviral mechanism of the TRIF pathway and describe the essential characteristics of TLR3 and its antiviral effects. Advancing our understanding of TLR3 may contribute to disease diagnosis and could foster the development of novel treatments for viral diseases."
}
